Evolus (EOLS) Cash from Operations (2017 - 2026)
Evolus (EOLS) reported Cash from Operations of 9952000.0 for Q1 2026, up 36.34% on a YoY basis from 7299627.63 in Q1 2025, and down 177.59% quarter-over-quarter from 12827000.0 in Q4 2025.
Evolus (EOLS) Cash from Operations (2017 - 2026) Analysis & Trends
Evolus has reported Cash from Operations for 10 years, with the latest figure at 9952000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 36.34% year-over-year to 9952000.0; the trailing twelve-month figure through Mar 2026 stood at 36585000.0 (down 58.95% YoY), and the FY2025 full-year result was 42265000.0, down 134.82% from the prior year.
- Cash from Operations for Q1 2026 stood at 9952000.0, down from 12827000.0 in the prior quarter.
- The five-year high for Cash from Operations was 12827000.0 in Q4 2025, with the low at 38199000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 11125647.06 across 5 years, with a median of 10615000.0 in 2024.
- The largest YoY upside for Cash from Operations was 491.39% in 2024 against a maximum downside of 519.26% in 2024.
- Evolus' Cash from Operations stood at 8774000.0 in 2022, then surged by 109.27% to 813000.0 in 2023, then surged by 491.39% to 4808000.0 in 2024, then surged by 166.78% to 12827000.0 in 2025, then plunged by 177.59% to 9952000.0 in 2026.
- The last three Cash from Operations figures came in at 9952000.0 (Q1 2026), 12827000.0 (Q4 2025), and 14669000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | -9.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.95 Mn |
| Mar 31, 2026 | -9.95 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Sep 30, 2025 | -14.67 Mn |
| Sep 30, 2025 | -14.67 Mn |
| Jun 30, 2025 | -24.79 Mn |
| Jun 30, 2025 | -24.79 Mn |
| Mar 31, 2025 | -15.63 Mn |
| Mar 31, 2025 | -15.63 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Jun 30, 2024 | -6.47 Mn |
| Jun 30, 2024 | -6.47 Mn |
| Mar 31, 2024 | -10.62 Mn |
| Mar 31, 2024 | -10.62 Mn |
| Dec 31, 2023 | 813,000.00 |
| Dec 31, 2023 | 813,000.00 |